MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 78 filers reported holding MUSTANG BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 600 | -97.8% | 0.00% | – |
| Q1 2022 | $28,000 | -39.1% | 27,900 | 0.0% | 0.00% | – |
| Q4 2021 | $46,000 | -38.7% | 27,900 | -0.3% | 0.00% | – |
| Q3 2021 | $75,000 | -27.9% | 27,987 | -10.6% | 0.00% | – |
| Q2 2021 | $104,000 | +1.0% | 31,304 | +1.3% | 0.00% | – |
| Q1 2021 | $103,000 | +66.1% | 30,900 | +89.6% | 0.00% | – |
| Q4 2020 | $62,000 | +21.6% | 16,300 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -1.9% | 16,300 | 0.0% | 0.00% | – |
| Q2 2020 | $52,000 | +18.2% | 16,300 | 0.0% | 0.00% | – |
| Q1 2020 | $44,000 | -34.3% | 16,300 | 0.0% | 0.00% | – |
| Q4 2019 | $67,000 | +26.4% | 16,300 | 0.0% | 0.00% | – |
| Q3 2019 | $53,000 | -11.7% | 16,300 | 0.0% | 0.00% | – |
| Q2 2019 | $60,000 | +7.1% | 16,300 | 0.0% | 0.00% | – |
| Q1 2019 | $56,000 | +16.7% | 16,300 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -50.5% | 16,300 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | -23.0% | 16,300 | -10.9% | 0.00% | – |
| Q2 2018 | $126,000 | – | 18,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 125,000 | $336,000 | 0.45% |
| Spotlight Asset Group, Inc. | 305,312 | $821,000 | 0.41% |
| GSA CAPITAL PARTNERS LLP | 560,215 | $1,507,000 | 0.15% |
| Ikarian Capital, LLC | 506,033 | $1,360,000 | 0.10% |
| EMFO, LLC | 31,000 | $83,000 | 0.07% |
| Bridgewater Advisors Inc. | 45,000 | $121,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 253,275 | $682,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 294,300 | $792,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 1,235,200 | $3,323,000 | 0.01% |
| Cypress Capital Management LLC (WY) | 2,950 | $8,000 | 0.01% |